Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients

Steroid-resistant GvHD is one of the most significant causes of mortality following allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Treatment with mesenchymal stromal cells (MSC) seems to be a promising solution, however the results from clinical studies are still equivocal. Better select...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinden, Liad, Avner, Mordechai, Stepensky, Polina, Or, Reuven, Almogi-Hazan, Osnat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561566/
https://www.ncbi.nlm.nih.gov/pubmed/31188842
http://dx.doi.org/10.1371/journal.pone.0217572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561566/
https://www.ncbi.nlm.nih.gov/pubmed/31188842
http://dx.doi.org/10.1371/journal.pone.0217572

Ejemplares similares